Search for: "MERCK " Results 1 - 20 of 3,332
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Mar 2024, 7:03 am by FRANK VINLUAN - MEDCITY NEWS
The drug comes from Merck’s $11.5 billion acquisition of Acceleron Pharma. [read post]
On 18 January 2024, in case C-367/21 (still no English version) the CJEU ruled again on the exhaustion of EU trade mark rights (following its five rulings of 17 November 2022 including C-175/21 Harman International Industries, C-224/20 Merck Sharp & Dohme, and C‑204/20 Bayer Intellectual Property). [read post]
6 Mar 2024, 2:23 pm by Ronald V. Miller, Jr.
March 2024 Foxamax Lawsuit Update Lawyers for patients involved in litigation against Merck regarding its osteoporosis drug Fosamax, which is alleged to increase the risk of painful bone fractures, argued before a Third Circuit panel on Tuesday that a letter from the FDA rejecting changes to the drug’s label does not constitute a final agency action triggering federal preemption of state law failure-to-warn claims. [read post]
5 Mar 2024, 11:47 am by Kurt R. Karst
By Faraz Siddiqui —Last Friday, the Delaware District Court rejected AstraZeneca’s lawsuit against the Medicare Drug Price Negotiation Program enacted under the Inflation Reduction Act (IRA) and CMS’s guidance implementing it. [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
5 Mar 2024, 10:23 am by Dennis Crouch
Sanofi Pasteur and Merck Sharp & Dohme (the “petitioners”) challenged the validity of the ‘559 patent claims in five inter partes review (IPR) proceedings, arguing they were obvious over prior art references disclosing multivalent pneumococcal vaccines. [read post]
29 Feb 2024, 9:01 am by Seeger Weiss
With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. [read post]
19 Feb 2024, 8:15 pm by Chris Castle
I think Tiffany is also hitting at a point that Merck Mercuriadis made at the last Artist Rights Symposium: Let’s face it—this is insulting. [read post]
12 Feb 2024, 1:46 am by Brian Cordery (Bristows)
  It was held that the MA relied on by Merck was not the first MA because there were earlier authorisations for cladribine as a treatment for hairy cell leukaemia. [read post]
4 Feb 2024, 7:14 am by Simon Holzer (MLL Legal Ltd.)
A noteworthy exception is the dispute between Merck Sharp & Dohme LLC (MSD) versus Spirig HealthCare AG (Spirig, a Stada subsidiary). [read post]
1 Feb 2024, 9:39 am by Mark Ashton
Typically, they earn a salary far less than their brethren at Merck, Pfizer, IBM or DuPont. [read post]
18 Jan 2024, 3:20 am
Jane Lambert Patents Court (Michael Tappin KC) Merck Serono SA v Comptroller-General of Patents, Designs and Trade Marks [2023] EWHC 3240 (Ch) (19 Dec 2023)This was an appeal by Merck Serono SA ("Merck") against Mary Taylor's refusal to grant a supplementary protection certificate ("SPC") in respect of cladribine (see Merck Serono S.A. v Comptroller 26 May 2023 BL O/ [read post]
17 Jan 2024, 7:38 am by Stewart Baker
Merck's effort to get insurance coverage for its NotPetya losses despite an act of war exclusion has been settled. [read post]
9 Jan 2024, 12:14 pm by Seeger Weiss
With the resources and dedication to take on the world’s largest corporations, the firm has an impressive track record of victories against companies like Merck, Monsanto, and 3M—and a reputation for sticking with a case from beginning to end. [read post]
Last year, China raided and arrested employees at prominent US consulting firms, including Merck Group and Bain & Company. [read post]
3 Jan 2024, 12:08 am by Adeline Chong
Guest post by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University Merck Sharp & Dohme Corp (formerly known as Merck & Co, Inc) v Merck KGaA (formerly known as E Merck) [2021] 1 SLR 1102, [2021] SGCA 14 (“Merck”), noted previously, is a landmark case in Singapore private international law, being a decision of a full bench of the Court of Appeal… [read post]